SCHEMBL16205992

SCHEMBL16205992

COc1ccc(-c2cccc(OCc3c(C)cccc3-n3nnn(C)c3=O)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 5/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
HPGD P15428 2/20 0.36
MAPT P10636 2/20 0.36
PDE10A Q9Y233 1/20 0.35
MAPK1 P28482 1/20 0.34
CTSA P10619 1/20 0.34
LMNA P02545 2/20 0.34
TDP1 Q9NUW8 2/20 0.33
POLB P06746 1/20 0.33
APEX1 P27695 1/20 0.33
RECQL P46063 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPBWR1 P48145 2/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
TNKS O95271 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17615143 0.91 ADORA2A (0.35) ALDH1A1KDM4EPKMTSHRHPGD
SCHEMBL16206095 0.91 HTR7 (0.34) MAPTCTSAHTR7
SCHEMBL16206108 0.91 MCL1 (0.33) ALDH1A1KDM4EPKMHPGDMAPT
SCHEMBL16206006 0.91 SLC16A3 (0.36) ALDH1A1KDM4EHPGDMAPTCTSA
SCHEMBL17615160 0.90 ALDH1A1 (0.38) ALDH1A1KDM4EPKMTSHRHPGD
SCHEMBL16205996 0.90 GABRA5 (0.36) ALDH1A1PKMTSHRPDE10AHTR7
SCHEMBL19772475 0.90 SMN1; SMN2 (0.35) ALDH1A1KDM4EPKMMAPTPDE10A
SCHEMBL16205955 0.90 CHEK1 (0.38) ALDH1A1KDM4EPKMTSHRHPGD
SCHEMBL17615238 0.90 MEN1 (0.40) ALDH1A1KDM4EPKMTSHRHPGD
SCHEMBL17615159 0.90 ALDH1A1 (0.35) ALDH1A1KDM4EPKMTSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990404-B1 TETRAZOLINONE COMPOUND AND USE OF SAME SUMITOMO CHEMICAL CO (JP) 2020-05-27 EP disclosed
US-9867372-B2 Tetrazolinone compound and use of same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-16 US disclosed
US-20160081339-A1 TETRAZOLINONE COMPOUND AND USE OF SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-24 US disclosed
WO-2014175465-A1 TETRAZOLINONE COMPOUND AND USE OF SAME 住友化学株式会社 (JP) 2014-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160081339-A1 TETRAZOLINONE COMPOUND AND USE OF SAME MT-CO1, SOD1, MT-CO2 ALDH1A1 1179/4885KDM4E 2422/4885PKM 799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.